Answers are grounded in this paper and cite their sources.
Randomized trial demonstrates improved depressive symptoms in late-life depression with active TBS treatment, suggesting its value.
The active TBS group did not have a statistically significant greater reduction in HAM-D scores compared to the sham group at week 6. By week 12, however, active TBS was superior to sham stimulation in reducing depressive symptoms in patients with late-life depression, suggesting TBS as a possible treatment option for this population.
No takes yet. Share an insight, caveat, or question.
Valiengo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: